55910-274 NDC - REXALL ASPIRIN ()

Drug Information

  • Product NDC: 55910-274
  • Proprietary Name: rexall aspirin
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: Dolgencorp, LLC
Product Type:
FDA Application Number: part343
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date:8/19/2010
End Marketing Date:7/31/2022

Package Information

No. Package Code Package Description Billing Unit
155910-274-232 BOTTLE in 1 CARTON (55910-274-23) / 36 TABLET, CHEWABLE in 1 BOTTLE

NDC Record

Field Name Field Value Definition
PRODUCT NDC55910-274This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
PROPRIETARY NAMErexall aspirinName of Company corresponding to the labeler code segment of the Product NDC.
START MARKETING DATE8/19/2010This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE7/31/2022 
MARKETING CATEGORY NAMEOTC MONOGRAPH NOT FINALProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERpart343This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEDolgencorp, LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025

Previous Code
Next Code